Zach Scheiner

Director/Board Member at NKARTA, INC.

Net worth: - $ as of 2026-05-30

49 year

96 connections

Health Technology

Finance

Consumer Services

Profile

Zach Scheiner is currently an Independent Director at SpyGlass Pharma, Inc. since 2023, Director at Adagio Medical, Inc. since 2020, Director at LENZ Therapeutics Operations, Inc. since 2020, Independent Director at Nkarta, Inc. since 2020, Director at Exo Imaging, Inc. since 2021, Director at Sydnexis, Inc. since 2017, Independent Director at LENZ Therapeutics, Inc. since 2024, Principal at RA Capital Management LP (Private Equity) since 2017, and Principal at RA Capital Management LP since 2015.
Formerly, served as Chief Science Officer at California Institute for Regenerative Medicine from 2008 to 2015.
Education includes a doctorate from the University of Washington conferred in 2007 and an undergraduate degree from Yale University conferred in 1997.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
-.--%	2026-06-14	0 ( -.--% )	- $	2026-05-30
NKARTA, INC. -.--%	2026-06-09	0 ( -.--% )	- $	2026-05-30
SPYGLASS PHARMA, INC. -.--%	2026-02-04	0 ( -.--% )	- $	2026-05-30

Zach Scheiner active positions

Companies	Position	Start
NKARTA, INC.	Director/Board Member	2020-01-31
SPYGLASS PHARMA, INC.	Director/Board Member	2023-06-30
RA Capital Management LP RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization.	Analyst-Equity	2015-03-31
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Private Equity Investor	2017-11-30
Adagio Medical, Inc. Adagio Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses in cardiology	Director/Board Member	2020-10-31
Exo Imaging, Inc. Exo Imaging, Inc. Packaged SoftwareTechnology Services Operates as an AI-based medical imaging software and devices company	Director/Board Member	2021-05-31
Sydnexis, Inc. Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	2017-09-30
LENZ Therapeutics, Inc. LENZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops aceclidine-based eye drops	Director/Board Member	2020-10-31

All active positions of Zach Scheiner

Former positions of Zach Scheiner

Companies	Position	End
California Institute for Regenerative Medicine California Institute for Regenerative Medicine General GovernmentGovernment Provides medical services	Chief Tech/Sci/R&D Officer	2015-02-28

See the detail of Zach Scheiner's experience

Training of Zach Scheiner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zach Scheiner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
RA Capital Management LP RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization.	Finance
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
California Institute for Regenerative Medicine California Institute for Regenerative Medicine General GovernmentGovernment Provides medical services	Government
Adagio Medical, Inc. Adagio Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses in cardiology	Health Technology
Exo Imaging, Inc. Exo Imaging, Inc. Packaged SoftwareTechnology Services Operates as an AI-based medical imaging software and devices company	Technology Services
Sydnexis, Inc. Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Nkarta, Inc. Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment	Health Technology
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Finance
LENZ Therapeutics, Inc. LENZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops aceclidine-based eye drops	Health Technology
SpyGlass Pharma Inc SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients	Health Technology